Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA.
暂无分享,去创建一个
Kazuya Yamano | Shigeru Iida | Mitsuo Satoh | S. Iida | Naoko Yamane-Ohnuki | Masako Wakitani | K. Shitara | M. Satoh | Y. Kanda | Kazuhisa Uchida | Katsuhiro Mori | Reiko Kuni-Kamochi | Rinpei Niwa | Yutaka Kanda | Naoko Yamane-Ohnuki | Masako Wakitani | Kenya Shitara | Rinpei Niwa | Kazuhisa Uchida | K. Yamano | H. Imai | Reiko Kuni-Kamochi | Katsuhiro Mori | Harue Imai
[1] H. Prydz,et al. Hammerhead ribozyme design and application , 1998, Cellular and Molecular Life Sciences (CMLS).
[2] K. Taira,et al. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. , 2003, Antisense & nucleic acid drug development.
[3] L. Chasin,et al. Effect of gamma rays at the dihydrofolate reductase locus: Deletions and inversions , 1986, Somatic cell and molecular genetics.
[4] P. Stanley,et al. Lectin-resistant CHO cells: Selection of four new pea lectin-resistant phenotypes , 1986, Somatic cell and molecular genetics.
[5] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[6] K. Shitara,et al. Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody. , 2000, Molecular immunology.
[7] L. Presta,et al. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.
[8] K. Taira,et al. U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells , 2002, Nature Biotechnology.
[9] J. Davies,et al. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. , 2001, Biotechnology and bioengineering.
[10] P. Gleeson,et al. Medial Golgi but Not Late Golgi Glycosyltransferases Exist as High Molecular Weight Complexes , 2000, The Journal of Biological Chemistry.
[11] S L Morrison,et al. Effect of glycosylation on antibody function: implications for genetic engineering. , 1997, Trends in biotechnology.
[12] James E. Bailey,et al. Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity , 1999, Nature Biotechnology.
[13] G. Salles,et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. , 2002, Blood.
[14] H. Okano,et al. Translational repression determines a neuronal potential in Drosophila asymmetric cell division , 2001, Nature.
[15] T. Tuschl,et al. Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.
[16] Debra Robertson,et al. US FTC probes practices of 100 companies , 2001, Nature Biotechnology.
[17] B. Kumpel,et al. The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment. , 1995, Human antibodies and hybridomas.
[18] T. Pederson,et al. Upstream elements required for efficient transcription of a human U6 RNA gene resemble those of U1 and U2 genes even though a different polymerase is used. , 1988, Genes & development.
[19] B. Li,et al. Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.
[20] M. Matsuoka,et al. High-level expression of maize phosphoenolpyruvate carboxylase in transgenic rice plants , 1999, Nature Biotechnology.
[21] C. Wilson,et al. Position effects on eukaryotic gene expression. , 1990, Annual review of cell biology.
[22] K. Taira,et al. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. , 2003, Nucleic acids research.
[23] N Taniguchi,et al. Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. , 1997, Journal of biochemistry.
[24] P. Carter,et al. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies , 1993, Cancer Immunology, Immunotherapy.
[25] R. Jefferis,et al. IgG‐Fc‐mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation , 1998, Immunological reviews.
[26] P. Stanley,et al. Two Chinese hamster ovary glycosylation mutants affected in the conversion of GDP-mannose to GDP-fucose. , 1986, Archives of biochemistry and biophysics.
[27] C. Bennett,et al. Antisense oligonucleotides as a tool for gene functionalization and target validation. , 1999, Biochimica et biophysica acta.
[28] T. Rademacher,et al. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. , 1994, Human antibodies and hybridomas.
[29] Shigeru Iida,et al. Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity , 2004, Biotechnology and bioengineering.
[30] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[31] Tyra G. Wolfsberg,et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Shitara,et al. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.
[33] M. Amarzguioui,et al. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. , 2002, Nucleic acids research.
[34] L. Presta,et al. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.
[35] K Weber,et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. , 2001, Journal of cell science.
[36] K. Shitara,et al. Defucosylated Chimeric Anti-CC Chemokine Receptor 4 IgG1 with Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma , 2004, Cancer Research.